Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25368014 | 0.77 | ALOX5 (0.30) | — | |
| SCHEMBL409149 | 0.75 | — | — | |
| Ammonia Solution, Strong SCHEMBL28681250 | 0.73 | — | — | |
| SCHEMBL1478088 | 0.72 | — | — | |
| SCHEMBL6901310 | 0.68 | — | — | |
| Ethylamine SCHEMBL962553 | 0.68 | — | — | |
| SCHEMBL8022701 | 0.66 | — | — | |
| SCHEMBL3691445 | 0.66 | — | — | |
| SCHEMBL16225377 | 0.65 | — | — | |
| SCHEMBL2337894 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1417209-B1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORP (US) | 2008-01-16 | — | — | EP | claimed |
| EP-1417209-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | Crompton Corporation (US) | 2004-05-12 | — | — | EP | claimed |
| WO-2003014130-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORPORATION (US) | 2003-02-20 | — | — | WO | claimed |
| US-6475347-B1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION | 2002-11-05 | — | — | US | claimed |
| EP-1417209-B1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORP (US) | 2008-01-16 | — | — | EP | disclosed |
| EP-1417209-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | Crompton Corporation (US) | 2004-05-12 | — | — | EP | disclosed |
| US-20030065177-A1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION, A CORPORATION OF THE STATE OF DELAWARE | 2003-04-03 | — | — | US | disclosed |
| WO-2003014130-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORPORATION (US) | 2003-02-20 | — | — | WO | disclosed |
| US-6475347-B1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION | 2002-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065177-A1 | High boiling inhibitors for distillable, polymerizable monomers | ROS1, POLR1A, ACP1 | IDO1 3398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.